We further examined TGF-β1 and one of its receptors TGFR2 in NPC tissues ex vivo and found a down-regulation of TGF-β1 in tumour cells and up-regulation of TGFR2 in clinical NPC samples. Here, TGFBR2 is linked to nasopharyngeal carcinoma.